Micro Therapeutics Inc, Dba Ev3 Neurovascular

11 dispositifs dans la base de données

  • Modèle / numéro de série
    All lot numbers: Product Number: UDI (a) REF 300010: 00843889031334, 00843889031341, 00847536020207 (b) REF 300011: 00843889031365, 00843889031372, 00847536020214 (c) REF 300012: 00843889031396, 00843889031402, 00847536020221 (d) REF 300013: 00843889031426, 00843889031433, 00847536020238 (e) REF 300014: NOT DISTRIBUTED (f) REF 300015: 00847536020122, 00847536020160 (g) REF 300016: 00847536020139, 00847536020177 (h) REF 300017: 00847536020146, 00847536020184 (i) REF 300018: 00847536020153, 00847536020191
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution
  • Description du dispositif
    MindFrame Capture LP Revascularization Devices: Product Numbers: || (a) REF 300010 || (b) REF 300011 || (c) REF 300012 || (d) REF 300013 || (e) REF 300014 || (f) REF 300015 || (g) REF 300016 || (h) REF 300017 || (i) REF 300018 || Intended to restore blood flow by removing thrombus from a large intracranial vessel experiencing ischemic stroke within 8 hours of symptom onset.
  • Modèle / numéro de série
    PED Model/ Lot  FA7735014 / 9879718  FA7742512 / 9864827 FA7150035 / 9855921 FA7735016 / 9856429  FA7742518 / 9856431 FA7730010 / 9869991  FA7737514 / 9855933  FA7742518 / 9860762 FA7732514 / 9873854  FA7737516 / 9858010  FA7745014 / 9874111 FA7735014 / 9855265  FA7740016 / 9859214  FA7745016 / 9879736 FA7735014 / 9875267  FA7740016 / 9879180  FA7747514 / 9868888
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution-USA (nationwide) including Puerto Rico and the countries of Australia, Germany, France, UK, Turkey, Argentina, Canada, Colombia, Mexico, , Austria, Belgium, Denmark, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Russia, Slovakia, Slovenia, Spain, Switzerland, and UAE.
  • Description du dispositif
    Pipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the internal carotid artery.
  • Modèle / numéro de série
    ARD Model/ Lot  FA8881040 / 9769118  FA8881030 / 9816048 FA8881040 / 9754682  FA8881050 / 9772283  FA8881040 / 9752800 FA8881030 / 9751662  FA8881030 / 9773525  FA8881020 / 9832735 FA8881040 / 9757667  FA8881020 / 9774620  FA8881030 / 9834039 FA8881040 / 9758530  FA8881020 / 9774620  FA8881030 / 9834039 FA8881030 / 9758532  FA8881030 / 9783730  FA8881020 / 9836553 FA8881050 / 9760946  FA8881040 / 9786013  FA8881030 / 9834039 FA8881030 / 9761690  FA8881040 / 9787928  FA8881050 / 9848544 FA8881020 / 9761692  FA8881030 / 9791385  FA8881030 / 9848543 FA8881030 / 9758532  FA8881040 / 9793305  FA8881030 / 9853152 FA8881040 / 9764206  FA8881030 / 9798648  FA8881030 / 9854769 FA8881040 / 9764206  FA8881030 / 9798648  FA8881030 / 9858153 FA8881040 / 9764212  FA8881050 / 9801041  FA8881030 / 9865759 FA8881030 / 9766949  FA8881020 / 9811215  FA8881050 / 9868025 FA8881030 / 9769117  FA8881030 / 9813908
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution-USA (nationwide) including Puerto Rico and the countries of Australia, Germany, France, UK, Turkey, Argentina, Canada, Colombia, Mexico, , Austria, Belgium, Denmark, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Russia, Slovakia, Slovenia, Spain, Switzerland, and UAE.
  • Description du dispositif
    Alligator Retrieval Device (ARD). Used in the peripheral and neurovasculature for foreign body removal.
  • Modèle / numéro de série
    Model/Lot Numbers:  FA-71400-25 / 9747602  FA-77350-18 / 9749412  FA-77400-20 / 9759088 FA-71500-35 / 9747604  FA-77375-16 / 9744487  FA-77425-16 / 9752788 FA-77300-16 / 9757068  FA-77375-20 / 9757065  FA-77425-20 / 9744123 FA-77325-14 / 9759141  FA-77400-14 / 9757233  FA-77425-20 / 9752438 FA-77325-16 / 9753034  FA-77400-14 / 9768698  FA-77450-18 / 9753033 FA-77325-16 / 9757024  FA-77400-16 / 9743468  FA-77475-20 / 9752787 FA-77325-18 / 9759560  FA-77400-18 / 9751579  FA-77500-20 / 9750678 FA-77350-16 / 9752785  FA-77400-20 / 9755707
  • Classification du dispositif
  • Classe de dispositif
    3
  • Dispositif implanté ?
    Yes
  • Distribution
    US Distribution including the states of AZ, KY, MO, NC, GA, WI, OR, FL, NY, CA, IL, TN, NV, TX, CO, MA, IA, UT and VA.
  • Description du dispositif
    Pipeline Embolization Device (PED) || The Pipeline Embolization Device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide-necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments.
  • Modèle / numéro de série
    Lot # 9374298
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution - US Nationwide including the states: MN, FL, OR, TX and the countries of: Brazil, Belgium, Czech Republic, Finlind, France, Germany, Netherlands, Poland, and United Kingdom.
  • Description du dispositif
    UltraFlow HPC Flow Directed Micro Catheter, Model # 105-5065. || Product Usage: || The UltraFlow HPC Flow Directed Micro Catheter is intended to access peripheral and neuro vasculature for the controlled selective infusion of physician-specified therapeutic agents such as embolization materials and of diagnostic materials such as contrast media.
6 en plus

Un fabricant avec un nom similaire

En savoir plus sur les données ici

  • Adresse du fabricant
    Micro Therapeutics Inc, dba ev3 Neurovascular, 9775 Toledo Way, Irvine CA 92618-1811
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    USFDA